Nastasiia I. Artamonova
Innsbruck, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Personalized therapy in metastatic hormone-sensitive prostate cancer: a 2026 update on navigating therapeutic complexity.
Journal: Current opinion in urology
Published: July 04, 2026
Integration of Darolutamide in the Treatment Landscape for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Network Meta-analysis of Efficacy and Safety.
Journal: European urology open science
Published: November 21, 2025
Real-world monitoring strategies and predictors guiding the transition from active surveillance to treatment in ISUP 1 prostate cancer.
Journal: Journal of cancer research and clinical oncology
Published: September 22, 2025
Redefining prostate cancer care: innovations and future directions in active surveillance.
Journal: Current opinion in urology
Published: February 18, 2025
The Clinical Trajectory of Prostate Cancer Patients Harboring Rare Histological Subtypes-A Retrospective Cohort Trial.
Journal: Clinical genitourinary cancer
Published: November 24, 2024
Impact of Renin-Angiotensin System Inhibitors on Disease Characteristics in Patients with Localized Prostate Cancer Treated with Radical Prostatectomy: A European Association of Urology Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study.
Journal: European urology open science
Published: September 14, 2024
Safety and Efficacy of 177Lu-PSMA Therapy Following 223Radium Treatment: A Retrospective Multinational Real-World Analysis.
Journal: Clinical genitourinary cancer
Published: September 02, 2024
Unraveling molecular characteristics and tumor microenvironment dynamics of neuroendocrine prostate cancer.
Journal: Journal of cancer research and clinical oncology
Published: June 30, 2024
The anti-diabetic PPARγ agonist Pioglitazone inhibits cell proliferation and induces metabolic reprogramming in prostate cancer.
Journal: Molecular cancer
Published: June 24, 2024
Small cell neuroendocrine prostate cancer with adenocarcinoma components-case report and literature review.
Journal: Translational andrology and urology
Published: October 25, 2023
Real-World Evidence of Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: An Austrian Multicenter Study.
Journal: Clinical genitourinary cancer
Published: October 12, 2023
Last Updated: 09/26/2026